Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07336277Phase 3Not Yet Recruiting

Sleep Quality and the Efficacy of a Multimodal Sleep Pathway in Hospitalized Orthopedic Trauma Patients

Role: collaborator

NCT07103252Not ApplicableNot Yet Recruiting

Blood Flow Restriction Therapy to Optimize Muscle Size and Strength in Recovery From Lower Limb Fractures

Role: collaborator

NCT03779425Not ApplicableCompleted

VR-Based Physical Therapy Pilot Study

Role: collaborator

NCT00843973Completed

Osteogenic Cell Viability in Bone Graft

Role: collaborator

NCT00679393Not ApplicableCompleted

Comparative Study of Fixation or Fusion of Calcaneal Fractures

Role: collaborator

All 5 trials loaded